Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +37.79%
#3 Bedrock Bedrock +21.47%
#4 Cysic Cysic +18.33%
#5 Fabric Protocol Fabric Protocol +15.99%
#6 Nockchain Nockchain +11.27%
#7 Perle Perle +10.69%
#8 Arowana Arowana +9.51%
#9 Cap Cap +7.41%
#10 stake.link stake.link +6.74%
Coin of the day
EXOD EXOD
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
BerGenBio ASA BerGenBio ASA

BerGenBio ASA

BGBIO
Classement en actions #37880
BerGenBio ASA is a biopharmaceutical firm in the clinical development stage,... BerGenBio ASA is a biopharmaceutical firm in the clinical development stage, focused on developing therapies for drug-resistant, immune-evasive, and metastatic cancers, in addition to respiratory conditions. Its leading compound, Bemcentinib, is a bio-available small molecule AXL inhibitor currently in Phase II clinical trials for major cancer indications and COVID-19. The Phase II trial program specifically addresses non-small cell lung cancer, acute myeloid leukemia, myelodysplastic syndrome, and COVID-19. Moreover, the company is progressing tilvestamab, an anti-AXL antibody, through Phase Ib clinical trials. BerGenBio ASA also maintains a collaboration agreement with Merck & Co. for its clinical studies. The company was founded in 2007 and operates from its base in Bergen, Norway.
Prix de l'action
$0.051239
Dernière synchronisation: 2025-11-24
Capitalisation boursière
$1.38M
Changement (1 jour)
-4.48%
Changement (1 an)
-54.57%
Pays
NO
Échange BerGenBio ASA (BGBIO)

Catégorie

Healthcare
Historique du prix de l'action pour BerGenBio ASA (BGBIO)
Prix de clôture le plus élevé : $0.08 le 2025-11-01

Prix de clôture le plus bas : $45.81 le 2017-04-01
Historique du prix de l'action de BerGenBio ASA de 2017 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 36.04%
2025 -90.51%
2024 -63.90%
2023 -73.76%
2022 -63.83%
2021 -44.23%
2020 73.06%
2019 -30.98%
2018 -3.30%
2017 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE